1. People's Republic of China Stocks

  2. •

    Industrials

  3. •

    Industrial - Machinery
Whole Shine Medical Technology Co., Ltd.

Whole Shine Medical Technology Co., Ltd.

002622.SZ
Whole Shine Medical Technology Co., Ltd.CN flagShenzhen Stock Exchange
2.08
CNY
-0.09
- -
1.75BMarket Cap
Whole Shine Medical Technology Co., Ltd.
002622.SZ
(Shenzhen Stock Exchange)

Recent

price

2.08

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.66
0.55
0.29
0.22
0.19
0.18
0.15
0.24
0.46
0.19
0.14
0.2
0.6
0.9
1.03
0.84
0.57
Revenue per Share
0.13
0.14
0.06
0.05
0.05
0.11
0.02
0.09
0.04
0.01
-0.35
-0.09
-0.31
-0.11
-0.04
-0.14
-0.13
Basic EPS, GAAP
0.13
0.09
-0.01
0.04
-0.08
-0.02
-0.05
-0.22
-0.01
0.03
0.08
0.02
0.01
0.12
0.09
0.05
-0.02
Free Cash Flow per Basic Share
0.04
- -
0.05
- -
0.01
0.2
- -
0.02
0.04
0.05
0.07
0.04
0.03
0.03
0.02
0.02
0.01
Dividend per Share
0.48
0.64
0.51
0.56
0.59
0.86
1.45
1.51
1.34
1.46
1.1
1.03
0.73
0.5
0.46
0.32
0.3
Book Value per Share
0.45
1.65
1.27
1.34
1.35
1.33
1.42
1.13
1.16
1.24
0.95
0.7
0.38
0.26
0.23
0.09
0.09
Tangible Book Value per Share
625
667
847
833
859
822
784
799
921
836
840
840
840
840
839
840
842
Basic Weighted Avg Shares
413
365
245
185
161
147
120
195
422
155
114
168
501
757
862
703
482
Sales/Revenue/Turnover
23.25
25.13
14.75
8.52
9.4
5.91
-30.75
9.34
-1.84
1.12
11.56
2.16
-12.91
10.12
6.47
-2.63
-5.43
Operating Margin (%)
8
9
10
12
11
12
15
18
20
14
188
16
63
64
64
56
- -
Depreciation Expense
83
92
54
39
47
90
16
72
37
7
-297
-76
-257
-94
-38
-119
-113
Net Income, GAAP
13.18
13.15
14.55
18.73
12.75
5.18
- -
10.04
40.9
41.12
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
20.03
25.09
22.24
20.94
29.34
61.68
13.05
36.89
8.72
4.79
-259.85
-45.2
-51.29
-12.47
-4.37
-16.99
-23.44
Profit Margin (%)
160
973
947
964
546
410
358
137
135
3
-58
-170
-548
-589
-591
-642
-643
Working Capital
4
4
3
3
2
2
2
200
99
- -
79
242
191
161
151
128
126
LT Debt
309
1,128
1,138
1,176
1,220
1,154
1,170
1,255
1,344
1,265
871
879
569
465
443
312
307
Total Equity
23.41
10.58
2.74
1.12
1.06
0.63
- -
1.18
-0.27
0.06
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
24.83
23.07
7.4
8.57
8.83
13.96
- -
6.05
3.51
1.82
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
30.42
25.16
12.67
8.6
9.72
14.91
1.7
6.14
3.02
0.61
-27.72
-8.48
-34.69
-18.26
-9.35
-36.8
-35.95
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
323
322
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
128
126
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
840
840
Market Capitalization
2,696
2,502
2,325

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
262
257
Cash, Cash Equivalents & STI
- -
137
136
Accounts Receivable, Net
- -
25
21
Inventories
- -
42
46
Total Current Liabilities
- -
904
899
Payables & Accruals
- -
- -
- -
ST Debt
- -
323
322
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-10.83%
-17.41%
-29.67%
Free Cash Flow
118.48%
193.84%
-43.85%
Net Income, GAAP
-368.84%
51.41%
216.85%
Sales/Revenue/Turnover
36.28%
58.29%
-18.42%
Total Cash Common Dividend
28.26%
-20.71%
-8.38%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
164
219
253
227
862
2025
143
171
- -
176
703
2026
135
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.01
- -
- -
- -
-0.04
2025
-0.01
- -
- -
- -
-0.14
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.02
2025
- -
- -
- -
- -
0.02
2026
- -
- -
- -
- -
- -
Similar Companies
Nabtesco Corporation (6268.T)
Shuanghua Holdings Limited (1241.HK)
Incon Engineers Limited (INCON.BO)
Xerium Technologies, Inc. (XRM)
Weichai Power Co., Ltd. (WI4.VI)
Rajoo Engineers Ltd. (RAJOOENG.NS)
Business
Whole Shine Medical Technology Co., Ltd. (002622.SZ) develops, manufactures, and sells medical devices focused on minimally invasive surgical solutions, including endoscopic systems, disposable endoscopic instruments, and related accessories. Its core product portfolio encompasses high-definition endoscopes such as gastroscopes, duodenoscopes, colonoscopes, and bronchoscopes; disposable devices like biopsy forceps, injection needles, snares, and retrieval nets; and supporting equipment including endoscopic processors, light sources, and insufflators. The company primarily serves hospitals, clinics, and medical institutions in the healthcare sector, with operations centered in China and expanding into international markets in Asia and beyond. Founded in 2006 and headquartered in Zhuhai, Guangdong Province, China, Whole Shine Medical operates through subsidiaries dedicated to research, production, and distribution, positioning it as a key player in China's endoscopy market. In recent developments, the company completed a strategic acquisition of a majority stake in a leading disposable endoscope accessories manufacturer in 2024, enhancing its production capacity and product diversification. It also launched new generations of 4K ultra-high-definition endoscopic systems and AI-assisted diagnostic tools in late 2024, aimed at improving procedural accuracy and efficiency. Additionally, Whole Shine Medical secured a significant funding round from institutional investors in early 2025 to support research and development in robotic-assisted endoscopy and global market expansion.